Abstract Submission for an Oral Presentation
Oral Presentation Submission Deadline: 10 November 2008
If you would like to submit a proposal for an oral presentation at this meeting, please click here to view the information required for your submission.
When ready just return to this page and fill out the form accordingly.
All abstracts will be reviewed by the Scientific Advisory Board and applicants will be notified of the result in due course.
Successful applicants will be provided with all necessary information.
Abstract Content:
- Written in English
- Written in the third person
- Include title, name(s) and affiliation(s) of the authors
- Between 100 - 200 words
- Suitable for direct publication in the proceedings pack and on the website
- Related to the subject of the conference
Agenda Topics:
- Reviews of Company Pipelines
- Clinical Trial Status of Nucleic Acid-Based Therapeutics
- Patent Status of Nucleic Acid-Based Diagnostics and Therapeutics
- Nucleic Acid Drug Delivery
- microRNAs as Diagnostics and Therapeutic Entities
- Nucleic Acid Biomarkers for Personalized Medicine
- Reimbursement and Regulatory Landscape
- Investor Attitudes to this Sector
- Emerging Company Showcase
Copyrights
The presenting author/person who submitted the abstract assumes full responsibility of the content of the abstract and we assume that all co-authors are aware of this content. Please note that your biography, summary and abstract may be used on this website and conference materials.
Please send any queries to: h.read@selectbiosciences.com